OR WAIT null SECS
© 2024 MJH Life Sciences and BioPharm International. All rights reserved.
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Editor of Pharmaceutical Technology Europe
AstraZeneca has completed its acquisition of Icosavax, gaining the IVX-A12 vaccine candidate that targets RSV and hMPV.
GSK is expanding its respiratory biologics portfolio with its acquisition of Aiolos Bio and its novel therapy, AIO-001.
NICE has recommended the use of AbbVie's Tepkinly as a treatment option for eligible adults with diffuse large B-cell lymphoma.
Despite slow growth over recent years, the CAR-T cell therapy space is expected to see considerable advancements in the near future.
IMU Biosciences has secured £11.5 million in its Series A financing round.
The acquisition marks a pivotal expansion for the company into the US market.
CellVoyant has raised £7.6 million in seed funding to speed up the development of novel cell therapies.
The largest biotech hub is set to be built in Lithuania by Northway Group.
Hovione has acquired start-up company, ExtremoChem, expanding its technology platforms.
UK industry body, ABPI, has responded positively to the recent Autumn Statement.